Where's My Batch? The Visibility Gap in Batch Release
By Whitney Smith, Scientific, Sales and Product Expertise in Life Science Software and Services
If you manage quality in a regulated lab, you already know the real story of batch release. It isn't told in your LIMS or your QMS. It's told in the spreadsheet someone built three years ago to track what those systems don't show: where a batch is right now, who's waiting on what, and why release is going to slip again this week.
That spreadsheet usually works, for a while. Then someone builds a second one for their part of the process. Then a third, for another site. Each one is accurate for the person who owns it and invisible to everyone else. The result is a QC/QA organization with more data than it has ever had, and less shared visibility into what that data means for release timing.
What the Gap Actually Costs
The data isn't missing. It's scattered, and scattered data has predictable costs.
Your most experienced QA people spend part of every week chasing status instead of reviewing. Release dates become negotiations rather than forecasts. Problems that were knowable early surface late: a missing document or an open deviation is discovered at the end of the review queue instead of the start. And a simple question, “where's my batch?”, still gets answered by phone, one system and one person at a time.
None of this shows up as a line item. It shows up as friction, slippage, and a steady drain on the people you can least afford to lose to administrative work.
How Organizations Tend to Close It
There isn't one right answer. There are four common approaches, each with a real trade-off:
Consolidate onto a single system of record. This is the cleanest answer in principle. In practice it is usually a multi-year program with revalidation attached, and it rarely covers every step a release decision touches.
Build dashboards on top of existing systems. These are fast to stand up and good at showing what happened. They are weaker at showing what's blocking a release right now, and maintaining the data pipeline becomes its own job.
Lean on review-by-exception inside the MES or LIMS. This is powerful within one system's walls, but a release decision usually spans several systems.
Add a coordination layer above existing systems. This leaves your systems of record in place and assembles the cross-system view. It is only as good as its integrations, and it is one more tool to validate.
The better question isn't which approach is best. It's which approach fits your systems, your sites, and your organization's appetite for change.
Where this Matters Most
The gap is widest where batch release status lives across multiple systems and multiple teams: multi-site manufacturers, CDMOs, and any lab where “where's my batch?” takes three phone calls and a spreadsheet to answer. If your release process already runs cleanly through one well-integrated system, with full visibility for everyone who needs it, you're an outlier in a good way. For most regulated labs, that isn't the reality yet.
How 20/15 Visioneers Helps
We start with your process, not with a product. That means mapping where release status actually lives, where decisions stall, and which of the approaches above fits your environment. Sometimes the answer is a better report built on systems you already own. Sometimes it's a platform, and when it is, we'll tell you plainly whether it's one we partner with (see “By the Way”).
If batch release visibility is a recurring headache for your team, we're glad to talk it through.
Talk to 20/15 →
Not Just Batch Release: A Pattern We Keep Seeing
Batch release is one example of something we see in nearly every knowledge-intensive part of life sciences: early-phase discovery, clinical trials, manufacturing, and regulatory affairs. The data needed to make a decision usually already exists. It's spread across operational systems that each do their own job well, but none of them was built to answer the question the decision-maker is actually asking.
What teams need is a smarter roll-up. That means pulling federated operational data together without forcing it all into one system. It means setting that data alongside the external data and process guidance that give it meaning. And it means presenting it in the shape of the decision at hand.
Two capabilities make or break these systems. The first is high-quality data integration, because every conclusion is only as trustworthy as the lineage beneath it. The second is AI trained for the domain: tools that understand the vocabulary, rules, and regulatory context of the work. Without the first, the second has nothing reliable to reason over.
By the Way: Where We Have a Stake
Since it's relevant to this topic, here is our disclosure: 20/15 Visioneers is the US partner for Q_alizer™, a Swiss platform built around the coordination-layer approach described above. We think it's a strong example of that approach, so it's worth a short introduction.
Q_alizer AG was founded in 2021 in Baar, Switzerland, by people who came out of QC and QA roles in the pharmaceutical and chemical industries and lived with the spreadsheet problem themselves. Rather than replacing LIMS, QMS, ERP, or MES, the platform sits above them and gives QC and QA teams a shared view of where every batch stands.
It's a young company with a mature product. The practitioner origin shows in the details: workflows built for GxP from the start, and transparent logic rather than a black box.
Being a partner doesn't change how we advise. If a different approach fits your operation better, we'll say so. If you'd like to see whether q_alizer fits yours, we're happy to show you.
Ask us about q_alizer →
Source: q-alizer.com/about
Signs Your Batch Release Has a Visibility Gap
Answering “where's my batch?” takes more than one phone call or email.
Teams or sites keep their own trackers for status your core systems don't show.
Release dates are negotiated rather than predicted.
Missing documents or open deviations surface at the end of review, not the start.
Your most experienced QA people spend part of every week chasing status.
A request for a release forecast gets a best guess.
If three or more of these sound familiar, you're in good company, and there's more than one way to close the gap.
Comments